lumacaftor vs Vanzacaftor / tezacaftor / deutivacaftor

Same mechanism, same race: design-graded trial evidence for both assets, with the grading rationale shown. Grades describe the quality of the evidence, never the merits of either security.

Cystic Fibrosis

Shared mechanism: CFTR · full Cystic Fibrosis pipeline

lumacaftor · Orkambi

Marketed by Vertex Pharmaceuticals

Approved in Cystic Fibrosissmall molecule
Reliable signal

NCT01807949 · Phase 3 · completed

The trial was randomized, double-blind, placebo-controlled, and included 563 participants. The hard clinical primary endpoint, change in percent-predicted FEV1, was significantly better with both lumacaftor/ivacaftor regimens than placebo: the treatment differences were 2.62 percentage points (p=0.0004) and 3.00 percentage points (p<0.0001).

No aligned efficacy figure on record for this race.

Vanzacaftor / tezacaftor / deutivacaftor · Alyftrek

Marketed by Vertex Pharmaceuticals

Approved in Cystic Fibrosissmall molecule
Reliable signal

NCT05033080 · Phase 3 · completed

This was a randomized, quadruple-blind trial in 398 treated patients comparing the new combination against the active standard-of-care regimen. The primary endpoint, lung function (ppFEV1) at 24 weeks, met the pre-specified non-inferiority criterion (p<0.0001), with the new combination numerically matching or slightly exceeding the comparator (difference +0.2 percentage points, 95% CI -0.7 to 1.1).

Next expected readout: July 2029 · NCT05844449 (registry estimate)

No aligned efficacy figure on record for this race.

Results for Cystic Fibrosis

There are not yet structured results for two selected drugs in this indication. Available results are listed below instead of an empty comparison table.

lumacaftor: registry results are on file for Cystic Fibrosis, but their comparison mappings are not yet available.

Vanzacaftor / tezacaftor / deutivacaftor: registry results are on file for Cystic Fibrosis, but their comparison mappings are not yet available.

The full competitive landscape for each asset (every same-race competitor with aligned evidence, sortable) is on the asset pages: lumacaftor's landscape · Vanzacaftor / tezacaftor / deutivacaftor's landscape